tiprankstipranks
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
Holding ATRA?
Track your performance easily

Atara Biotherapeutics (ATRA) Financial Statements

1,116 Followers

Atara Biotherapeutics Financial Overview

Atara Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-25.657; its P/E ratio is -0.41; Atara Biotherapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-3.32. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 40.19M$ 28.64M$ 27.36M$ 2.14M$ 957.00K
Gross Profit$ 40.19M$ 28.64M$ 27.36M$ -477.00K$ 957.00K
EBIT$ -20.74M$ -17.79M$ -55.95M$ -68.42M$ -69.73M
EBITDA$ -19.51M$ -16.46M$ -54.56M$ -67.21M$ -68.53M
Net Income Common Stockholders$ -21.91M$ -19.05M$ -31.75M$ -69.80M$ -71.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 67.19M$ 35.29M$ 46.24M$ 102.41M$ 153.64M
Total Assets$ 142.71M$ 117.28M$ 165.27M$ 188.79M$ 246.44M
Total Debt$ 35.24M$ 38.70M$ 42.20M$ 48.51M$ 51.75M
Net Debt$ -31.95M$ 3.41M$ -4.04M$ -53.90M$ -101.89M
Total Liabilities$ 233.25M$ 228.15M$ 263.58M$ 239.63M$ 238.99M
Stockholders Equity$ -90.54M$ -110.87M$ -98.31M$ -50.84M$ 7.45M
Cash Flow-
Free Cash Flow$ -3.99M$ -10.67M$ -29.74M$ -51.63M$ -53.30M
Operating Cash Flow$ -3.99M$ -10.64M$ -29.61M$ -51.35M$ -52.80M
Investing Cash Flow$ -16.66M$ 7.20M$ 14.72M$ 70.45M$ 49.48M
Financing Cash Flow$ 35.79M$ -324.00K$ 24.14M$ -208.00K$ 471.00K
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Atara Biotherapeutics Debt to Assets

Atara Biotherapeutics Cash Flow

Atara Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis